Tumor tissues from the left tumors were collected and digested with Liberase TL (Catalog No. 05401020001, Roche) and DNase I (Catalog No. 10104159001, Roche) for 30 min at 37 °C, and prepared into single-cell suspension as reported in our previous study [12]. Antibodies used in staining and flow analysis included CD45 (Clone 30-F11), CD3 (Clone 17A2), CD4 (Clone GK1.5), CD8 (Clone 53–6.7), NK1.1 (Clone PK136), LAG3 (Clone C9B7W), Foxp3 (Clone 3G3), CD11b-BV650 (Clone M1/70), MHC-II (Clone AF6-120.1), CD11c (Clone N418), CD206 (Clone C068C2), F4/80 (Clone BM8) and CD103 (Clone M290). Intracellular cytokine staining was also performed as described in previous study [12]. Following stimulation, the cells were labeled with antibodies against surface markers, fixed, and permeabilized using the Invitrogen Fixing/Permeabilization Solution kit’s manufacturer’s instructions. Antibodies against TNF-α (Clone MP6-XT22) and IFN-γ (Clone XMG1.2) were used to stain the fixed cells. A BD FACS Aria II flow cytometer was used to collect data, which were then analyzed using FlowJo software.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.